Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
SAN FRANCISCO, Dec. 29 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and...
Trial Utilizes Positron Emission Tomography with Flurodeoxyglucose Tracer (FDG-PET) Non Invasive Imaging SAN FRANCISCO, Dec. 3 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a...
SAN FRANCISCO, Oct. 13 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and...
SAN FRANCISCO, Sept. 28 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and...
SAN FRANCISCO, Sept. 18 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and...
SAN FRANCISCO, July 17 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (NASDAQ:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 750 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 417 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 3003 | 1.0E-6 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 38051 | 1.0E-6 | CS |
| 260 | -0.004699 | -99.9787234043 | 0.0047 | 0.04 | 1.0E-6 | 30404 | 0.00848831 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
